What are the major opportunities in the atopic dermatitis market? What are the strategies for the atopic dermatitis market?

For detailed insights on the major opportunities and strategies in the atopic dermatitis market, Read More

How does the atopic dermatitis market relate to the overall economy and other similar markets?

For detailed insights on atopic dermatitis market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the atopic dermatitis market growth? SWOT analysis of the atopic dermatitis market.

For detailed insights on the key dynamics influencing the atopic dermatitis market growth and SWOT analysis of the atopic dermatitis industry, Read More

Atopic Dermatitis Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Atopic Dermatitis Market Report 2026

Name: Atopic Dermatitis Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Class (Corticosteroids, Emollients Or Moisturizers, IL-4 And PDE4 Inhibitors, Calcineurin Inhibitors, Other Drug Classes), By Mode of Administration (Topical, Injectable, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Atopic Dermatitis Market Overview

• Atopic Dermatitis market size has reached to $9.88 billion in 2025

• Expected to grow to $19.53 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%

• Growth Driver: Increasing Demand For Personalized Medicine Drives The Atopic Dermatitis Market

• Market Trend: Adoption Of Targeted IL-31 Receptor Antagonists In Atopic Dermatitis Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Atopic Dermatitis Market?

Atopic dermatitis is a dermatological condition that causes dryness and itching of the skin. It is a chronic condition that progresses over time and is not spread by contact.

The main drug classes to treat atopic dermatitis include corticosteroids, emollients/moisturizers, IL-4 and PDE4 inhibitors, calcineurin inhibitors, antibiotics, and others. Corticosteroids refer to anti-inflammatory drugs that resemble cortisol and are used to treat a variety of diseases such as rheumatological diseases, rheumatoid arthritis, lupus, and atopic dermatitis. These are delivered through various modes of administration, including topical, injectable, and oral, and sold through several distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

Atopic Dermatitis Market Global Report 2026 Market Report bar graph

What Is The Atopic Dermatitis Market Size and Share 2026?

The atopic dermatitis market size has grown rapidly in recent years. It will grow from $9.88 billion in 2025 to $11.34 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to increasing prevalence of chronic skin conditions, wider availability of topical corticosteroids, expansion of dermatology care services, growing awareness of eczema management, improved diagnostic accuracy.

What Is The Atopic Dermatitis Market Growth Forecast?

The atopic dermatitis market size is expected to see rapid growth in the next few years. It will grow to $19.53 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing adoption of biologics and JAK inhibitors, rising focus on personalized dermatology treatments, expansion of injectable therapy options, growing investment in dermatology research, increasing demand for long-term symptom control. Major trends in the forecast period include increasing adoption of biologic therapies, rising demand for targeted immunomodulators, growing focus on long-term disease management, expansion of advanced topical formulations, enhanced emphasis on patient-centric treatment.

Book your 30 minutes free consultation with our research experts

Global Atopic Dermatitis Market Segmentation

1) By Drug Class: Corticosteroids, Emollients Or Moisturizers, IL-4 And PDE4 Inhibitors, Calcineurin Inhibitors, Other Drug Classes

2) By Mode of Administration: Topical, Injectable, Oral

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids

2) By Emollients Or Moisturizers: Creams and Lotions, Ointments and Balms, Barrier Repair Creams

3) By IL-4 And PDE4 Inhibitors: Dupilumab (IL-4 Inhibitor), Apremilast (PDE4 Inhibitor)

4) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream

5) By Other Drug Classes: Biologics, JAK Inhibitors

What Is The Driver Of The Atopic Dermatitis Market?

The increasing demand for personalized medicine is expected to propel the growth of the atopic dermatitis market going forward. Personalized medicine refers to an innovative approach to medical treatment and healthcare that tailors medical decisions, practices, interventions, and drug therapies to the individual patient. Personalized medicine in atopic dermatitis involves the identification of specific genetic and molecular factors influencing the disease, enabling the development of targeted therapies that address the unique characteristics of each patient. This approach not only enhances treatment efficacy but also minimizes adverse effects. For instance, in February 2024, the Personalized Medicine Coalition, a US-based advocacy group for tailored medical treatments, said the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the atopic dermatitis industry.

Key Players In The Global Atopic Dermatitis Market

Major companies operating in the atopic dermatitis market are Sanofi SA, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., GlaxoSmithKline PLC, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Allergan PLC, Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eisai Co. Ltd., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited

Global Atopic Dermatitis Market Trends and Insights

Major companies are operating in the atopic dermatitis market focusing on developing innovative therapies such as IL-31 receptor antagonists to address chronic itch, improve skin symptom control, and reduce systemic side effects compared to traditional corticosteroids or immunosuppressants. An IL-31 receptor antagonist works by blocking the IL-31 signaling pathway, which is directly involved in itch sensation and inflammation, offering a more targeted approach than broad immune suppression. For instance, in December 2024, Galderma, a Switzerland-based dermatology company, received FDA approval for Nemluvio (nemolizumab), the first monoclonal antibody that specifically targets the IL-31 receptor alpha to inhibit IL-31 signaling in moderate-to-severe atopic dermatitis. The therapy is administered via subcutaneous injection, binds to the IL-31 receptor to prevent activation by the IL-31 cytokine, and has been shown in clinical trials to provide rapid relief from itch and meaningful improvement in skin symptoms when used alongside topical treatments.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Atopic Dermatitis Market?

In September 2024, Organon, a US-based healthcare company, acquired Dermavant Sciences Ltd. for up to US$ 1.2 billion. Through this acquisition, Organon aims to expand its dermatology and immune-mediated skin disease portfolio by integrating Dermavant’s VTAMA® (tapinarof) cream and advancing its development for atopic dermatitis in adults and children. Dermavant Sciences Ltd. is a U.S.-based immuno-dermatology company that provides VTAMA® (tapinarof) cream, a once-daily, non-steroidal topical therapy targeting immune-mediated skin conditions.

Regional Outlook

North America was the largest region in the atopic dermatitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Atopic Dermatitis Market?

The atopic dermatitis market consists of sales of biologics, CNI immunosuppressant drugs, and skin barrier emollients. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Atopic Dermatitis Market Report 2026?

The atopic dermatitis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the atopic dermatitis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Atopic Dermatitis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$11.34 billion
Revenue Forecast In 2035	$19.53 billion
Growth Rate	CAGR of 14.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Class, Mode of Administration, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Sanofi SA, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., GlaxoSmithKline PLC, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Allergan PLC, Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eisai Co. Ltd., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Atopic Dermatitis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Atopic Dermatitis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Atopic Dermatitis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Atopic Dermatitis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Biologic Therapies

4.2.2 Rising Demand For Targeted Immunomodulators

4.2.3 Growing Focus On Long-Term Disease Management

4.2.4 Expansion Of Advanced Topical Formulations

4.2.5 Enhanced Emphasis On Patient-Centric Treatment

5. Atopic Dermatitis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Dermatology Clinics

5.3 Specialty Pharmacies

5.4 Research Institutes

5.5 Home Healthcare Providers

6. Atopic Dermatitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Atopic Dermatitis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Atopic Dermatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Atopic Dermatitis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Atopic Dermatitis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Atopic Dermatitis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Atopic Dermatitis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Atopic Dermatitis Market Segmentation

9.1. Global Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Corticosteroids, Emollients Or Moisturizers, IL-4 And PDE4 Inhibitors, Calcineurin Inhibitors, Other Drug Classes

9.2. Global Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Topical, Injectable, Oral

9.3. Global Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.4. Global Atopic Dermatitis Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Topical Corticosteroids, Systemic Corticosteroids

9.5. Global Atopic Dermatitis Market, Sub-Segmentation Of Emollients Or Moisturizers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Creams and Lotions, Ointments and Balms, Barrier Repair Creams

9.6. Global Atopic Dermatitis Market, Sub-Segmentation Of IL-4 And PDE4 Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dupilumab (IL-4 Inhibitor), Apremilast (PDE4 Inhibitor)

9.7. Global Atopic Dermatitis Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tacrolimus Ointment, Pimecrolimus Cream

9.8. Global Atopic Dermatitis Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biologics, JAK Inhibitors

10. Atopic Dermatitis Market Regional And Country Analysis

10.1. Global Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Atopic Dermatitis Market

11.1. Asia-Pacific Atopic Dermatitis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Atopic Dermatitis Market

12.1. China Atopic Dermatitis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Atopic Dermatitis Market

13.1. India Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Atopic Dermatitis Market

14.1. Japan Atopic Dermatitis Market Overview

14.2. Japan Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Atopic Dermatitis Market

15.1. Australia Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Atopic Dermatitis Market

16.1. Indonesia Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Atopic Dermatitis Market

17.1. South Korea Atopic Dermatitis Market Overview

17.2. South Korea Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Atopic Dermatitis Market

18.1. Taiwan Atopic Dermatitis Market Overview

18.2. Taiwan Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Atopic Dermatitis Market

19.1. South East Asia Atopic Dermatitis Market Overview

19.2. South East Asia Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Atopic Dermatitis Market

20.1. Western Europe Atopic Dermatitis Market Overview

20.2. Western Europe Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Atopic Dermatitis Market

21.1. UK Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Atopic Dermatitis Market

22.1. Germany Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Atopic Dermatitis Market

23.1. France Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Atopic Dermatitis Market

24.1. Italy Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Atopic Dermatitis Market

25.1. Spain Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Atopic Dermatitis Market

26.1. Eastern Europe Atopic Dermatitis Market Overview

26.2. Eastern Europe Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Atopic Dermatitis Market

27.1. Russia Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Atopic Dermatitis Market

28.1. North America Atopic Dermatitis Market Overview

28.2. North America Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Atopic Dermatitis Market

29.1. USA Atopic Dermatitis Market Overview

29.2. USA Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Atopic Dermatitis Market

30.1. Canada Atopic Dermatitis Market Overview

30.2. Canada Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Atopic Dermatitis Market

31.1. South America Atopic Dermatitis Market Overview

31.2. South America Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Atopic Dermatitis Market

32.1. Brazil Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Atopic Dermatitis Market

33.1. Middle East Atopic Dermatitis Market Overview

33.2. Middle East Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Atopic Dermatitis Market

34.1. Africa Atopic Dermatitis Market Overview

34.2. Africa Atopic Dermatitis Market, Segmentation By Drug Class, Segmentation By Mode of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Atopic Dermatitis Market Regulatory and Investment Landscape

36. Atopic Dermatitis Market Competitive Landscape And Company Profiles

36.1. Atopic Dermatitis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Atopic Dermatitis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Atopic Dermatitis Market Company Profiles

36.3.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Atopic Dermatitis Market Other Major And Innovative Companies

Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., GlaxoSmithKline PLC, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Allergan PLC, Menlo Therapeutics Inc., Johnson & Johnson

38. Global Atopic Dermatitis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Atopic Dermatitis Market

40. Atopic Dermatitis Market High Potential Countries, Segments and Strategies

40.1 Atopic Dermatitis Market In 2030 - Countries Offering Most New Opportunities

40.2 Atopic Dermatitis Market In 2030 - Segments Offering Most New Opportunities

40.3 Atopic Dermatitis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Atopic Dermatitis Market, Overview Of Key Products - Product Examples

Table 2: Global Atopic Dermatitis Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Atopic Dermatitis Market, Supply Chain Analysis

Table 4: Global Atopic Dermatitis Market, Major Raw Material Providers

Table 5: Global Atopic Dermatitis Market, Major Resource Providers

Table 6: Global Atopic Dermatitis Market, Major Manufacturers (Suppliers)

Table 7: Global Atopic Dermatitis Market, Major Distributors And Channel Partners

Table 8: Global Atopic Dermatitis Market, Key Technologies & Future Trends

Table 9: Global Atopic Dermatitis Market, Major Trends

Table 10: Global Atopic Dermatitis Market, Major End Users

Table 11: Global Atopic Dermatitis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Atopic Dermatitis Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Atopic Dermatitis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Atopic Dermatitis Market - TAM, US$ Billion, 2025

Table 15: Global Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Atopic Dermatitis Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Atopic Dermatitis Market, Sub-Segmentation Of Emollients Or Moisturizers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Atopic Dermatitis Market, Sub-Segmentation Of IL-4 And PDE4 Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Atopic Dermatitis Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Atopic Dermatitis Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Atopic Dermatitis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Atopic Dermatitis Market - Company Scoring Matrix

Table 99: Sanofi SA Financial Performance

Table 100: Regeneron Pharmaceuticals Inc. Financial Performance

Table 101: Novartis International AG Financial Performance

Table 102: Pfizer Inc. Financial Performance

Table 103: AbbVie Inc. Financial Performance

Table 104: Global Atopic Dermatitis Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Atopic Dermatitis Market, Competitive Dashboard

Table 106: Global Atopic Dermatitis Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Atopic Dermatitis Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 108: Global, Atopic Dermatitis Market Size Gain ($ Billion), Segmentation By Mode of Administration, 2025 – 2030

Table 109: Global, Atopic Dermatitis Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Atopic Dermatitis Market, Overview Of Key Products - Product Examples

Figure 2: Global Atopic Dermatitis Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Atopic Dermatitis Market, Supply Chain Analysis

Figure 4: Global Atopic Dermatitis Market, Major Raw Material Providers

Figure 5: Global Atopic Dermatitis Market, Major Resource Providers

Figure 6: Global Atopic Dermatitis Market, Major Manufacturers (Suppliers)

Figure 7: Global Atopic Dermatitis Market, Major Distributors And Channel Partners

Figure 8: Global Atopic Dermatitis Market, Key Technologies & Future Trends

Figure 9: Global Atopic Dermatitis Market, Major Trends

Figure 10: Global Atopic Dermatitis Market, Major End Users

Figure 11: Global Atopic Dermatitis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Atopic Dermatitis Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Atopic Dermatitis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Atopic Dermatitis Market - TAM, US$ Billion, 2025

Figure 15: Global Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Atopic Dermatitis Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Atopic Dermatitis Market, Sub-Segmentation Of Emollients Or Moisturizers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Atopic Dermatitis Market, Sub-Segmentation Of IL-4 And PDE4 Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Atopic Dermatitis Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Atopic Dermatitis Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Atopic Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Atopic Dermatitis Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Atopic Dermatitis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Atopic Dermatitis Market - Company Scoring Matrix

Figure 99: Sanofi SA Financial Performance

Figure 100: Regeneron Pharmaceuticals Inc. Financial Performance

Figure 101: Novartis International AG Financial Performance

Figure 102: Pfizer Inc. Financial Performance

Figure 103: AbbVie Inc. Financial Performance

Figure 104: Global Atopic Dermatitis Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Atopic Dermatitis Market, Competitive Dashboard

Figure 106: Global Atopic Dermatitis Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Atopic Dermatitis Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 108: Global, Atopic Dermatitis Market Size Gain ($ Billion), Segmentation By Mode of Administration, 2025 – 2030

Figure 109: Global, Atopic Dermatitis Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Dermatitis Market Report 2026 - Global Outlook – By Drug Class (Corticosteroids, Emollients Or Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors ), By Distributio...

Dermatology Market Report 2026 - Global Outlook – By Type (Medical Dermatology, Surgical Dermatology, Pediatric Dermatology, Cosmetic Dermatology, Cutaneous Lymphoma, Dermatoimmunology, Other Types ), By Application (Acn...

Allergic Rhinitis Market Report 2026 - Global Outlook – By Type (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Corticosteroids, Immunotherapy, Dec...

Allergy Conjunctivitis Market Report 2026 - Global Outlook – By Drug Class (Antihistamines And Mast Cell Stabilizers, Corticosteroids, Other Drug Classes), By Disease Type (Mild, Severe), By Distribution Channel (Hospita...

Seborrheic Dermatitis Market Report 2026 - Global Outlook – By Treatment (Anti-Inflammatory, Antifungal, Corticosteroid, Sulfur Products, Other Treatments), By Dosage Form (Creams, Shampoos, Ointments, Gels, Other Dosage...

Allergy Treatment Market Report 2026 - Global Outlook – By Treatment Type (Anti-Allergy Drugs, Immunotherapy), By Type (Eye Allergy, Skin Allergy, Food Allergy, Rhinitis, Other Types), By Route of Administration (Oral, P...

Allergy Immunotherapy Market Report 2026 - Global Outlook – By Allergy Type (Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, Allergic Conjunctivitis, Environmental Allergies), By Treatment (Subcutaneous ...

Frequently Asked Questions

How big is the Atopic Dermatitis Market?

The Atopic Dermatitis market was valued at $9.88 billion in 2025, increased to $11.34 billion in 2026, and is projected to reach $19.53 billion by 2030. request a sample here

What is the Atopic Dermatitis market growth?

The global Atopic Dermatitis market is expected to grow at a CAGR of 14.6% from 2026 to 2035 to reach $19.53 billion by 2035. request a sample here

Who are the key players in Atopic Dermatitis market?

Some Key Players in the Atopic Dermatitis market Include, Sanofi SA, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., GlaxoSmithKline PLC, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Allergan PLC, Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eisai Co. Ltd., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited . request a sample here

What is the anticipated growth trend for the Atopic Dermatitis market?

Major trend in this market includes: Adoption Of Targeted IL-31 Receptor Antagonists In Atopic Dermatitis Treatment. For further insights on this market. request a sample here

Which region has the most growth potential in the Atopic Dermatitis market?

North America was the largest region in the atopic dermatitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atopic dermatitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Atopic Dermatitis Market Report 2026 market?

Major companies operating in the Atopic Dermatitis Market Report 2026 market are Major companies operating in the atopic dermatitis market are Sanofi SA, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., GlaxoSmithKline PLC, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Allergan PLC, Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eisai Co. Ltd., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited request a sample here.

Which region has the most growth potential in the Atopic Dermatitis Market Report 2026 market?